Spyre Therapeutics, Inc. SYRE

85.69 (1.40) (1.61%) as of 25 Sep

Follow SYRE

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(63.28%)	(33.69%)	(42.63%)	(28.52%)
ROA Full definition →		(32.19%)	(22.39%)	(26.91%)	(20.90%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(32.50%)	(21.58%)	(26.43%)	(16.12%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(2.68)	(2.64)	(2.36)	(2.47)
Free Cash Flow Full definition →		(161.87)	(169.25)	(185.63)	(208.94)
Other line items
Cash ROIC Full definition →		(17.20%)	(11.50%)	(13.14%)	(9.30%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		1.09	1.09	1.03	1.17
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(2.68)	(2.64)	(2.36)	(2.47)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Net Profit Margin Full definition →		0.00%	0.00%	0.00%	0.00%

Columns are period end dates

Powerpack